Invesaro

Stocks FLEX Financial statements

Financial statements

FLEX LTD. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data FLEX LTD. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue23,86325,44126,21124,21024,12424,63328,50226,41525,81327,914
Cost of revenue22,30323,77824,59422,68122,34922,83826,50324,39523,58425,288
Gross profit1,5211,5961,5181,3391,6871,7801,9761,8652,1592,567
Research and development65.678.2
Selling, general and administrative9371,0199538348178308749229041,052
Operating income4157958901,0178531,1691,368
Interest expense1081231467.2150166230207218215
Interest income12.118.81919141430566151
Other non-operating income-21.2170-120-82-16165-6-4414-30
Pre-tax income3715211821597149648076661,0231,143
Income tax51.392.4897110192124-206185263
Net income to minority interests00424023900
Net income32042993886139367931,006838880
EBITDA8371,2171,2991,4311,2841,6081,825
EPS, basic0.590.810.180.171.231.971.752.312.142.37
EPS, diluted0.590.800.180.171.211.941.722.282.112.33
Shares, basic (weighted)541530527509499476454435391371
Shares, diluted (weighted)546537530512506483462441398378

Balance sheet

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash and equivalents1,8311,4721,6971,9232,6372,9643,1642,4742,2892,389
Receivables2,1932,5182,6132,4363,9593,3713,4803,0333,6714,679
Inventory3,3963,8003,7233,7853,8956,5807,3886,2055,0715,845
Other current assets9681,3808556605909038751,0311,1942,356
Total current assets8,3889,1709,1039,08611,36314,33716,03312,99212,84116,332
Property, plant and equipment2,3172,2402,3362,2162,0972,1252,3422,2692,3302,505
Lease right-of-use assets0605642637605601562659
Goodwill9851,1211,0731,0651,0901,1381,1391,1351,3411,369
Intangible assets362424331262213411315245343283
Other non-current assets5427606564564314734901,015964912
Total assets12,59313,71613,49913,69015,83619,32521,40718,25718,38122,060
Accounts payable4,4855,1225,1475,1085,2476,2545,7244,4685,1478,055
Accrued liabilities344383392364473470506488560671
Deferred revenue329272362848615
Short-term debt61.54363314926894915001,2090
Total current liabilities6,5057,2687,5987,2117,83410,71110,8678,5399,85012,016
Long-term debt2,8912,8982,4222,6893,5153,2483,5443,2612,4833,751
Lease liabilities0529562551504490456565
Other non-current liabilities520532508430489608554642590584
Total liabilities9,91510,69710,52610,85912,40015,11815,70112,93213,37916,916
Total debt2,9682,9543,0652,8523,8044,1973,6943,2613,6923,751
Retained earnings-3,573-3,144-3,012-2,902-2,289-1,353-5604461,2842,164
Treasury stock-388-388-388-388-388-388-3880-200-200
Other comprehensive income-128-85.8-151-215-119-182-194-195-224-167
Shareholders' equity2,6453,0192,9722,8313,4364,1295,3515,3255,0025,144
Minority interests33.7003550
Total equity2,6783,0192,9732,8313,4364,1295,7065,3255,0025,144
Total liabilities and equity12,59313,71613,49913,69015,83619,32521,40718,25718,38122,060
Shares outstanding531528517497493461450408378366

Cash flow statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Net income31142193886139401,0331,245838880
Depreciation and amortization432434433422422409414431439457
Stock-based compensation77.381.376717991133152125142
Deferred income tax-21.538.6-127-5-441-3705538
Change in receivables-5,136-4,917-3,628-2,106-1,615624-388380-601-979
Change in inventory85-354-360-66-96-2,655-9741,1051,176-742
Change in payables26962368-15103969-341-9866302,858
Cash from operations-3,822-3,866-2,971-1,5331441,0249501,3261,5051,685
Capital expenditures-525-562-726-462-351-443-635-530-438-633
Acquisitions-189-268-13-10-53920-405-40
Cash from investing4,2703,7113,2532,279-202-951-604-492-838-672
Debt issued3131,3663,1991,0702,06575971824991,251
Stock issued12.42.770.250069455200
Share buybacks-350-180-189-260-183-686-337-1,298-1,257-944
Cash from financing-242-188-30-5087432802-1,656-821-924
Exchange rate effect17.5-15.1-27-1229-26-182-3111
Net change in cash223-358225226714327330-820-185100
Free cash flow-4,347-4,428-3,697-1,995-2075813157961,0671,052
Interest paid127153190172147169227226214212
Income taxes paid86.791.813499105122124243184323

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 26, 2026; growth uses fiscal years. Valuation uses the share price of $114.68 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin9.4%Gross profit / revenue.
Operating margin5.0%Operating income / revenue.
EBITDA margin6.6%EBITDA (operating income + depreciation and amortization) / revenue.
Net margin3.3%Net income / revenue.
FCF margin2.8%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin5.3%Cash from operations / revenue.
Return on equity (ROE)17.7%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)3.9%Net income / average total assets.
Return on invested capital (ROIC)14.5%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue3.9%Selling, general and administrative expense / revenue.
Stock-based pay / revenue0.5%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue2.5%Capital expenditures / revenue.
D&A / revenue1.6%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y8.1%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-0.7%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y3.0%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y18.9%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y9.1%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y8.8%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y17.0%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y10.4%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y11.5%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y13.5%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y8.4%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y8.4%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y5.0%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y3.5%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y7.5%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y10.4%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y10.6%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y14.0%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y12.0%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y21.0%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y63.5%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-1.4%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y49.5%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y2.8%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-1.3%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y8.4%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y20.0%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y1.0%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y6.9%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-5.0%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-6.5%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-5.7%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.38xCurrent assets / current liabilities.
Quick ratio0.60x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.21x(Cash + short-term investments) / current liabilities.
Debt / equity0.95xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets20.7%Total debt / total assets.
Liabilities / assets78.2%Total liabilities / total assets.
Net debt$2.38BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA1.23xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage6.47xOperating income / interest expense.
Working capital$5.02BCurrent assets - current liabilities.
Goodwill and intangibles / assets10.2%(Goodwill + intangible assets) / total assets.
Tangible book value$2.93BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.16xRevenue / average total assets.
Fixed asset turnover11.0xRevenue / average property, plant and equipment.
Inventory turnover4.10xCost of revenue / average inventory.
Days inventory89 days365 x average inventory / cost of revenue.
Receivables turnover5.81xRevenue / average receivables.
Days sales outstanding63 days365 x average receivables / revenue.
Days payables127 days365 x average accounts payable / cost of revenue.
Cash conversion cycle25 daysDays inventory + days sales outstanding - days payables.
FCF conversion84.9%Free cash flow / net income, when net income is positive.
Capex / operating cash flow47.1%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$2.60Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$78.25Revenue / diluted weighted shares.
FCF per share$2.21Free cash flow / diluted weighted shares.
Operating cash flow per share$4.18Cash from operations / diluted weighted shares.
Book value per share$14.89Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$7.94Tangible book value / shares outstanding.
Cash per share$7.69(Cash + short-term investments) / shares outstanding.
Buybacks / FCF84.4%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$42.36BShare price x shares outstanding.
Enterprise value$44.74BMarket cap + total debt - cash - short-term investments.
P/E43.5xMarket cap / net income. Only when net income is positive.
P/S1.45xMarket cap / revenue.
P/B7.70xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book14.4xMarket cap / tangible book value, when positive.
P/FCF51.3xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF27.1xMarket cap / cash from operations, when positive.
EV/Sales1.53xEnterprise value / revenue.
EV/EBIT30.9xEnterprise value / operating income, when both are positive.
EV/EBITDA23.2xEnterprise value / EBITDA, when both are positive.
EV/FCF54.2xEnterprise value / free cash flow, when both are positive.
FCF yield1.9%Free cash flow / market cap.
Earnings yield2.3%Net income / market cap (the inverse of P/E).
Shareholder yield1.6%(Dividends paid + share buybacks) / market cap.
PEG4.09xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was FLEX LTD.'s revenue in fiscal 2026?

FLEX LTD. reported revenue of $27.91B for fiscal 2026, 8.1% higher than the year before.

Was FLEX LTD. profitable in fiscal 2026?

Yes. Net income was $880.0M, a net margin of 3.2%.

How much free cash flow did FLEX LTD. generate in fiscal 2026?

Cash from operations of $1.69B minus capital expenditures of $633.0M left free cash flow of $1.05B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to FLEX LTD.